Drug
1-month DAPT
1-month DAPT is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
33%
Ph phase_4
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Active, not recruiting1
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (33.3%)
Phase 42 (66.7%)
Trials by Status
active_not_recruiting133%
recruiting133%
completed133%
Recent Activity
2 active trials
Showing 3 of 3
recruitingphase_3
Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy
NCT05952206
completedphase_4
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
NCT02619760
active_not_recruitingphase_4
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study
NCT04609111
Clinical Trials (3)
Showing 3 of 3 trials
NCT05952206Phase 3
Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy
NCT02619760Phase 4
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study
NCT04609111Phase 4
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3